The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model-Reference-Cited by-同舟云学术

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model

Published:2008-01-28 Issue:10 Volume:41 Page:895-904
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Sadeghi B,Jansson M,Hassan Z,Mints M,Hägglund H,Abedi-Valugerdi M,Hassan M

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/1705996.pdf

Reference45 articles.

1. Storb R . Allogeneic hematopoietic stem cell transplantation—yesterday, today, and tomorrow. Exp Hematol 2003; 31: 1–10.

2. Burt RK, Barr W, Oyama Y, Traynor A, Slavin S . Future strategies in hematopoietic stem cell transplantation for rheumatoid arthritis. J Rheumatol Suppl 2001; 64: 42–48.

3. Little MT, Storb R . History of haematopoietic stem-cell transplantation. Nat Rev Cancer 2002; 2: 231–238.

4. Vriesendorp HM . Aims of conditioning. Exp Hematol 2003; 31: 844–854.

5. Tutschka PJ, Santos GW . Bone marrow transplantation in the busulfan-treated rat. I. Effect of cyclophosphamide and rabbit antirat thymocyte serum as immunosuppression. Transplantation 1975; 20: 101–106.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cyclophosphamide Pharmacogenomic Variation in Cancer Treatment and Its Effect on Bioactivation and Pharmacokinetics;Advances in Pharmacological and Pharmaceutical Sciences;2024-01

2. Haploidentical transplant for paediatric patients with severe thalassaemia using post‐transplant cyclophosphamide and methotrexate: A prospectively registered multicentre trial from the Bone Marrow Failure Working Group of Hunan Province, China;British Journal of Haematology;2022-10-18

3. Addition of romiplostim to conditioning prior to HSCT allows chemotherapy reduction while maintaining engraftment levels;Blood Advances;2022-08-02

4. Effects of Chemotherapy on Neuroinflammation, Neuronal Damage, Neurogenesis, and Behavioral Performance in Bone Marrow Transplantation Recipient Mice;Neurotoxicity Research;2022-04

5. Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial;Annals of Hematology;2020-10-23